Wang Shuai, Wang Zhou, Liu Xiangyan, Yang Yu, Shi Mo, Sun Zhenguo
Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, No.324, Jingwu Road, Jinan, Shandong, 250021, People's Republic of China.
Tumour Biol. 2015 Aug;36(8):6181-9. doi: 10.1007/s13277-015-3302-9. Epub 2015 Mar 11.
Recent studies have shown that Ku80, a DNA repair protein, was involved in progression of malignant tumors. This study aimed to clarify the clinicopathological significance and prognostic value of Ku80 in pT2N0M0 esophageal squamous cell carcinoma (ESCC). We enrolled 217 patients with pT2N0M0 midthoracic ESCC who had undergone Ivor-Lewis esophagectomy. The expression profile of Ku80 was examined by immunohistochemistry. The results were correlated with the clinicopathological variables, overall survival (OS) and disease-free survival (DFS), in pT2N0M0 ESCC patients. The expression of Ku80 were higher in ESCC tissues than the corresponding health esophageal mucosa (P < 0.001). Clinically, the Ku80 expression levels were significantly related to tumor size (P = 0.018), differentiation degree (P = 0.010), and tumor-node-metastasis (TNM) stage (P = 0.001). Subsequent multivariate analysis demonstrated that tumor size, differentiation degree, TNM stage, and Ku80 expression were independent prognostic factors for the OS and the DFS of pT2N0M0 ESCC patients. Our data indicated that Ku80 expression level associates with key clinicopathological features and is an independent predictor of the OS and the DFS in pT2N0M0 ESCC patients.
近期研究表明,DNA修复蛋白Ku80参与恶性肿瘤的进展。本研究旨在阐明Ku80在pT2N0M0食管鳞状细胞癌(ESCC)中的临床病理意义及预后价值。我们纳入了217例行Ivor-Lewis食管切除术的pT2N0M0胸段中段ESCC患者。通过免疫组织化学检测Ku80的表达情况。将结果与pT2N0M0 ESCC患者的临床病理变量、总生存期(OS)和无病生存期(DFS)进行关联分析。Ku80在ESCC组织中的表达高于相应的健康食管黏膜(P < 0.001)。临床上,Ku80表达水平与肿瘤大小(P = 0.018)、分化程度(P = 0.010)和肿瘤-淋巴结-转移(TNM)分期(P = 0.001)显著相关。随后的多因素分析表明,肿瘤大小、分化程度、TNM分期和Ku80表达是pT2N0M0 ESCC患者OS和DFS的独立预后因素。我们的数据表明,Ku80表达水平与关键临床病理特征相关,是pT2N0M0 ESCC患者OS和DFS的独立预测指标。